{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:39Z","timestamp":1789042899163,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27720-4","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:36:33Z","timestamp":1765964193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular assessment of the HIV pol gene and use of computational vaccine design targeting Pakistani isolates"],"prefix":"10.1038","volume":"15","author":[{"given":"Akmal","family":"Zubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Maryam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Wdidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"2","key":"27720_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LCK Bell","year":"2018","unstructured":"Bell, L. C. K. & Noursadeghi, M. Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection. Nat. Rev. Microbiol. 16(2), 80\u201390 (2018).","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"27720_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/21645515.2019.1666957","volume":"16","author":"B Korber","year":"2020","unstructured":"Korber, B. & Fischer, W. T cell-based strategies for HIV-1 vaccines. Hum. Vaccin Immunother. 16(3), 713\u2013722 (2020).","journal-title":"Hum. Vaccin Immunother"},{"key":"27720_CR3","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.77031","author":"LI Karpenko","year":"2018","unstructured":"Karpenko, L. I. et al. Artificial epitope-based immunogens in HIV-vaccine design. Adv. HIV AIDS Control. https:\/\/doi.org\/10.5772\/intechopen.77031 (2018).","journal-title":"Adv. HIV AIDS Control"},{"issue":"18","key":"27720_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","volume":"298","author":"SW Roush","year":"2007","unstructured":"Roush, S. W. & Murphy, T. V. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Jama 298(18), 2155\u20132163 (2007).","journal-title":"Jama"},{"issue":"6336","key":"27720_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.356.6336.364","volume":"356","author":"M Wadman","year":"2017","unstructured":"Wadman, M. & You, J. The vaccine wars. Science 356(6336), 364\u2013365 (2017).","journal-title":"Science"},{"issue":"17","key":"27720_CR6","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2217\/nnm.14.187","volume":"9","author":"M Skwarczynski","year":"2014","unstructured":"Skwarczynski, M. & Toth, I. Recent advances in peptide-based subunit nanovaccines. Nanomedicine (Lond) 9(17), 2657\u20132669 (2014).","journal-title":"Nanomedicine (Lond)"},{"key":"27720_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","volume":"48","author":"N Hajighahramani","year":"2017","unstructured":"Hajighahramani, N. et al. Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus. Infect. Genet. Evol. 48, 83\u201394 (2017).","journal-title":"Infect. Genet. Evol."},{"key":"27720_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","volume":"62","author":"N Nezafat","year":"2016","unstructured":"Nezafat, N. et al. Designing an efficient multi-epitope peptide vaccine against vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Comput. Biol. Chem. 62, 82\u201395 (2016).","journal-title":"Comput. Biol. Chem."},{"issue":"14","key":"27720_CR9","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/JVI.00327-09","volume":"83","author":"NJ Steers","year":"2009","unstructured":"Steers, N. J. et al. Human immunodeficiency virus type 1 gag p24 alters the composition of immunoproteasomes and affects antigen presentation. J. Virol. 83(14), 7049\u20137061 (2009).","journal-title":"J. Virol."},{"issue":"44","key":"27720_CR10","doi-asserted-by":"publisher","first-page":"15158","DOI":"10.1074\/jbc.REV120.012317","volume":"295","author":"RP Staudt","year":"2020","unstructured":"Staudt, R. P. et al. Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes. J. Biol. Chem. 295(44), 15158\u201315171 (2020).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"27720_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11262-025-02149-z","volume":"61","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Molecular characterization and drug resistance pattern in pol gene of HIV-1 sub-subtypes circulating in Lahore, Pakistan. Virus Genes 61(3), 324\u2013341 (2025).","journal-title":"Virus Genes"},{"key":"27720_CR12","doi-asserted-by":"crossref","unstructured":"Zubair, A. et al. Current Challenges with Highly Active Antiretroviral Therapy and New Hope and Horizon with CRISPR-CAS9 Technology for HIV Treatment Vol. 105, e70121 (Chemical Biology & Drug Design, 2025).","DOI":"10.1111\/cbdd.70121"},{"issue":"6","key":"27720_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/hiv.70024","volume":"26","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. mRNA vaccines against HIV: Hopes and challenges. HIV Med. 26(6), 824\u2013838 (2025).","journal-title":"HIV Med."},{"issue":"1","key":"27720_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1742-4690-5-84","volume":"5","author":"JL Foster","year":"2008","unstructured":"Foster, J. L. & Garcia, J. V. HIV-1 nef: At the crossroads. Retrovirology 5(1), 84 (2008).","journal-title":"Retrovirology"},{"key":"27720_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fimmu.2019.01144","volume":"10","author":"S Kumar","year":"2019","unstructured":"Kumar, S., Sunagar, R. & Gosselin, E. Bacterial protein Toll-Like-Receptor agonists: A novel perspective on vaccine adjuvants. Front. Immunol. 10, 1144 (2019).","journal-title":"Front. Immunol."},{"issue":"13","key":"27720_CR16","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1080\/07391102.2018.1519460","volume":"37","author":"H Dorosti","year":"2019","unstructured":"Dorosti, H. et al. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J. Biomol. Struct. Dyn. 37(13), 3524\u20133535 (2019).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"27720_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12981-017-0165-8","volume":"14","author":"J Liu","year":"2017","unstructured":"Liu, J. & Ostrowski, M. Development of targeted adjuvants for HIV-1 vaccines. AIDS Res. Ther. 14(1), 43 (2017).","journal-title":"AIDS Res. Ther."},{"key":"27720_CR18","doi-asserted-by":"publisher","first-page":"104114","DOI":"10.1016\/j.micpath.2020.104114","volume":"143","author":"S Fereshteh","year":"2020","unstructured":"Fereshteh, S. et al. New putative vaccine candidates against acinetobacter baumannii using the reverse vaccinology method. Microb. Pathog. 143, 104114 (2020).","journal-title":"Microb. Pathog"},{"key":"27720_CR19","doi-asserted-by":"publisher","first-page":"806825","DOI":"10.3389\/fimmu.2022.806825","volume":"13","author":"B Shaker","year":"2022","unstructured":"Shaker, B. et al. Computational design of a multi-epitope vaccine against porphyromonas gingivalis. Front. Immunol. 13, 806825 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"27720_CR20","doi-asserted-by":"publisher","first-page":"13321","DOI":"10.1038\/s41598-019-49354-z","volume":"9","author":"M Khan","year":"2019","unstructured":"Khan, M. et al. Immunoinformatics approaches to explore helicobacter pylori proteome (virulence factors) to design B and T cell multi-epitope subunit vaccine. Sci. Rep. 9(1), 13321 (2019).","journal-title":"Sci. Rep."},{"issue":"Database issue","key":"27720_CR21","doi-asserted-by":"publisher","first-page":"D61","DOI":"10.1093\/nar\/gkl842","volume":"35","author":"KD Pruitt","year":"2007","unstructured":"Pruitt, K. D., Tatusova, T. & Maglott, D. R. NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35(Database issue), D61\u2013D65 (2007).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"27720_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3892\/ol.2010.193","volume":"1","author":"XM Zhang","year":"2010","unstructured":"Zhang, X. M. et al. Prediction and analysis of HLA-A2\/A24-restricted cytotoxic T-lymphocyte epitopes of the tumor antigen MAGE-n using the artificial neural networks method on NetCTL1. 2 server. Oncol. Lett. 1(6), 1097\u20131100 (2010).","journal-title":"Oncol. Lett."},{"issue":"23\u201324","key":"27720_CR23","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","volume":"22","author":"M Bhasin","year":"2004","unstructured":"Bhasin, M. & Raghava, G. P. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22(23\u201324), 3195\u20133204 (2004).","journal-title":"Vaccine"},{"issue":"suppl_2","key":"27720_CR24","doi-asserted-by":"publisher","first-page":"W72","DOI":"10.1093\/nar\/gki396","volume":"33","author":"J Cheng","year":"2005","unstructured":"Cheng, J. et al. SCRATCH: A protein structure and structural feature prediction server. Nucleic Acids Res. 33(suppl_2), W72\u2013W76 (2005).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"27720_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/pro.2206","volume":"22","author":"VP Reddy Chichili","year":"2013","unstructured":"Reddy Chichili, V. P., Kumar, V. & Sivaraman, J. Linkers in the structural biology of protein-protein interactions. Protein Sci. 22(2), 153\u2013167 (2013).","journal-title":"Protein Sci."},{"issue":"8","key":"27720_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2020.1842976","volume":"114","author":"S Yadav","year":"2020","unstructured":"Yadav, S. et al. Design of a multi-epitope subunit vaccine for immune-protection against leishmania parasite. Pathogens Global Health 114(8), 471\u2013481 (2020).","journal-title":"Pathogens Global Health"},{"key":"27720_CR27","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook 571\u2013607. (2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"27720_CR28","doi-asserted-by":"crossref","unstructured":"Saha, S. & Raghava, G. P. S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins Struct. Funct. Bioinform. 65(1), 40\u201348 (2006).","DOI":"10.1002\/prot.21078"},{"issue":"1","key":"27720_CR29","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","volume":"9","author":"RA Shey","year":"2019","unstructured":"Shey, R. A. et al. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci. Rep. 9(1), 4409 (2019).","journal-title":"Sci. Rep."},{"issue":"suppl_2","key":"27720_CR30","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35(suppl_2), W407\u2013W410 (2007).","journal-title":"Nucleic Acids Res."},{"key":"27720_CR31","doi-asserted-by":"crossref","unstructured":"Lovell, S. C. et al. Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation. Proteins Struct. Funct. Bioinform. 50(3), 437\u2013450 (2003).","DOI":"10.1002\/prot.10286"},{"key":"27720_CR32","doi-asserted-by":"crossref","unstructured":"Kim, H. J. et al. Toll-like Receptor 4 (TLR4): New Insight Immune and Aging Vol. 20, 7 (Immunity & Ageing, 2023).","DOI":"10.1186\/s12979-023-00383-3"},{"issue":"1","key":"27720_CR33","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","volume":"7","author":"M Ali","year":"2017","unstructured":"Ali, M. et al. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Sci. Rep. 7(1), 9232 (2017).","journal-title":"Sci. Rep."},{"issue":"20","key":"27720_CR34","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btr497","volume":"27","author":"JR Lop\u00e9z-Blanco","year":"2011","unstructured":"Lop\u00e9z-Blanco, J. R., Garz\u00f3n, J. I. & Chac\u00f3n, P. iMod: multipurpose normal mode analysis in internal coordinates. Bioinformatics 27(20), 2843\u20132850 (2011).","journal-title":"Bioinformatics"},{"issue":"4","key":"27720_CR35","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N. et al. Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 5(4), e9862 (2010).","journal-title":"PLoS One"},{"key":"27720_CR36","doi-asserted-by":"publisher","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","volume":"354","author":"S Ghahremanian","year":"2022","unstructured":"Ghahremanian, S. et al. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J. Mol. Liq. 354, 118901 (2022).","journal-title":"J. Mol. Liq."},{"issue":"9","key":"27720_CR37","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c7(1) and \u03c7(2) dihedral angles. J. Chem. Theory Comput. 8(9), 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"27720_CR38","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126(1), 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"27720_CR39","doi-asserted-by":"publisher","first-page":"120116","DOI":"10.1016\/j.molliq.2022.120116","volume":"365","author":"Q Ke","year":"2022","unstructured":"Ke, Q. et al. Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations. J. Mol. Liq. 365, 120116 (2022).","journal-title":"J. Mol. Liq."},{"issue":"10","key":"27720_CR40","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S. et al. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17(10), 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"27720_CR41","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.2147\/JIR.S515286","volume":"18","author":"J Ma","year":"2025","unstructured":"Ma, J. et al. Qimai feiluoping decoction inhibits EndMT to alleviate pulmonary fibrosis by reducing PI3K\/AKT\/mTOR pathway-mediated the restoration of autophagy. J. Inflamm. Res. 18, 8447\u20138475 (2025).","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"27720_CR42","doi-asserted-by":"publisher","first-page":"e0317382","DOI":"10.1371\/journal.pone.0317382","volume":"20","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the Asia. PLOS ONE 20(3), e0317382 (2025).","journal-title":"PLOS ONE"},{"issue":"10425","key":"27720_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","volume":"403","author":"A Mody","year":"2024","unstructured":"Mody, A. et al. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet 403(10425), 471\u2013492 (2024).","journal-title":"Lancet"},{"issue":"37","key":"27720_CR44","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","volume":"29","author":"MP Girard","year":"2011","unstructured":"Girard, M. P. et al. Human immunodeficiency virus (HIV) Immunopathogenesis and vaccine development: A review. Vaccine 29(37), 6191\u20136218 (2011).","journal-title":"Vaccine"},{"issue":"2","key":"27720_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/gt.2013.81","volume":"21","author":"M Smahel","year":"2014","unstructured":"Smahel, M. et al. The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization. Gene Ther. 21(2), 225\u2013232 (2014).","journal-title":"Gene Ther."},{"issue":"123","key":"27720_CR46","doi-asserted-by":"publisher","first-page":"123ra25","DOI":"10.1126\/scitranslmed.3003165","volume":"4","author":"DZ Soghoian","year":"2012","unstructured":"Soghoian, D. Z. et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl Med. 4(123), 123ra25 (2012).","journal-title":"Sci. Transl Med."},{"issue":"4","key":"27720_CR47","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/eji.201243088","volume":"43","author":"CX Chang","year":"2013","unstructured":"Chang, C. X. et al. Conditional ligands for Asian HLA variants facilitate the definition of CD8\u2009+\u2009T-cell responses in acute and chronic viral diseases. Eur. J. Immunol. 43(4), 1109\u20131120 (2013).","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"27720_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.0300-9475.2004.01442.x","volume":"60","author":"QM Wang","year":"2004","unstructured":"Wang, Q. M. et al. Epitope DNA vaccines against tuberculosis: Spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine. Scand. J. Immunol. 60(3), 219\u2013225 (2004).","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"27720_CR49","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.4049\/jimmunol.166.9.5366","volume":"166","author":"MP Velders","year":"2001","unstructured":"Velders, M. P. et al. Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J. Immunol. 166(9), 5366\u20135373 (2001).","journal-title":"J. Immunol."},{"issue":"9","key":"27720_CR50","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/mt.2012.98","volume":"20","author":"B Dai","year":"2012","unstructured":"Dai, B. et al. PD-1\/PD-L1 Blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines. Mol. Ther. 20(9), 1800\u20131809 (2012).","journal-title":"Mol. Ther."},{"issue":"3","key":"27720_CR51","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/JVI.72.3.2072-2078.1998","volume":"72","author":"MA Accola","year":"1998","unstructured":"Accola, M. A., H\u00f6glund, S. & G\u00f6ttlinger, H. G. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 gag precursor is crucial for viral particle assembly. J. Virol. 72(3), 2072\u20132078 (1998).","journal-title":"J. Virol."},{"issue":"1","key":"27720_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2020.1867163","volume":"51","author":"SH Shabani","year":"2022","unstructured":"Shabani, S. H. et al. In Silico and in vivo analysis of HIV-1 rev regulatory protein for evaluation of a multiepitope-based vaccine candidate. Immunol. Invest. 51(1), 1\u201328 (2022).","journal-title":"Immunol. Invest."},{"issue":"3","key":"27720_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10529-023-03464-x","volume":"46","author":"F Heidarnejad","year":"2024","unstructured":"Heidarnejad, F. et al. In Silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnol. Lett. 46(3), 315\u2013354 (2024).","journal-title":"Biotechnol. Lett."},{"issue":"8","key":"27720_CR54","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s10529-021-03143-9","volume":"43","author":"E Akbari","year":"2021","unstructured":"Akbari, E. et al. In Silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Biotechnol. Lett. 43(8), 1513\u20131550 (2021).","journal-title":"Biotechnol. Lett."},{"key":"27720_CR55","doi-asserted-by":"crossref","unstructured":"Saldanha, L., Langel, \u00dc. & Vale, N. In silico studies to support vaccine development. Pharmaceutics 15(2) (2023).","DOI":"10.3390\/pharmaceutics15020654"},{"issue":"1","key":"27720_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12879-024-09775-2","volume":"24","author":"A Hashempour","year":"2024","unstructured":"Hashempour, A. et al. Reverse vaccinology approaches to design a potent multiepitope vaccine against the HIV whole genome: Immunoinformatic, bioinformatics, and molecular dynamics approaches. BMC Infect. Dis. 24(1), 873 (2024).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"27720_CR57","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12864-023-09330-4","volume":"24","author":"H Sher","year":"2023","unstructured":"Sher, H. et al. Employing computational tools to design a multi-epitope vaccine targeting human immunodeficiency virus-1 (HIV-1). BMC Genom. 24(1), 276 (2023).","journal-title":"BMC Genom."},{"issue":"1","key":"27720_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41598-021-03990-6","volume":"12","author":"ACB Antonelli","year":"2022","unstructured":"Antonelli, A. C. B. et al. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools. Sci. Rep. 12(1), 53 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"27720_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12985-025-02764-0","volume":"22","author":"SK Mishra","year":"2025","unstructured":"Mishra, S. K. et al. Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: A study based on complete genome. Virol. J. 22(1), 228 (2025).","journal-title":"Virol. J."},{"issue":"9","key":"27720_CR60","doi-asserted-by":"publisher","first-page":"e0306559","DOI":"10.1371\/journal.pone.0306559","volume":"19","author":"A Hashempour","year":"2024","unstructured":"Hashempour, A. et al. Design of multivalent-epitope vaccine models directed toward the world\u2019s population against HIV-Gag polyprotein: Reverse vaccinology and immunoinformatics. PLoS One 19(9), e0306559 (2024).","journal-title":"PLoS One"},{"issue":"9","key":"27720_CR61","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1080\/07391102.2022.2055648","volume":"41","author":"W Ezzemani","year":"2023","unstructured":"Ezzemani, W. et al. Design of a multi-epitope Zika virus vaccine candidate\u2014An in-silico study. J. Biomol. Struct. Dyn. 41(9), 3762\u20133771 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"27720_CR62","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1038\/s41598-022-08506-4","volume":"12","author":"H Al Tbeishat","year":"2022","unstructured":"Al Tbeishat, H. Novel in silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications. Sci. Rep. 12(1), 4645 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"27720_CR63","first-page":"407","volume":"70","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1. Acta Biochim. Pol. 70(2), 407\u2013418 (2023).","journal-title":"Acta Biochim. Pol."},{"issue":"1","key":"27720_CR64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s43141-021-00206-2","volume":"19","author":"VNO de Leon","year":"2021","unstructured":"de Leon, V. N. O. et al. Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis. J. Genet. Eng. Biotechnol. 19(1), 104 (2021).","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"7","key":"27720_CR65","doi-asserted-by":"publisher","first-page":"112711","DOI":"10.1016\/j.celrep.2023.112711","volume":"42","author":"GT Holt","year":"2023","unstructured":"Holt, G. T. et al. Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in Silico design. Cell. Rep. 42(7), 112711 (2023).","journal-title":"Cell. Rep."},{"issue":"1","key":"27720_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s40203-021-00095-w","volume":"9","author":"M Behbahani","year":"2021","unstructured":"Behbahani, M., Moradi, M. & Mohabatkar, H. Silico design of a multi-epitope peptide construct as a potential vaccine candidate for influenza A based on neuraminidase protein. Silico Pharmacol. 9(1), 36 (2021).","journal-title":"Silico Pharmacol."},{"issue":"3","key":"27720_CR67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1573409919666230612125440","volume":"20","author":"I Farhani","year":"2024","unstructured":"Farhani, I. et al. Designing a multi-epitope vaccine against the SARS-CoV-2 variant based on an immunoinformatics approach. Curr. Comput. Aided Drug Des. 20(3), 274\u2013290 (2024).","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"27720_CR68","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41598-020-80899-6","volume":"11","author":"S Bibi","year":"2021","unstructured":"Bibi, S. et al. In Silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci. Rep. 11(1), 1249 (2021).","journal-title":"Sci. Rep."},{"key":"27720_CR69","doi-asserted-by":"crossref","unstructured":"Slathia, P. S. & Sharma, P. In Silico designing of vaccines: Methods, tools, and their limitations. In Computer-Aided Drug Design 245\u2013277 (Springer, 2020).","DOI":"10.1007\/978-981-15-6815-2_11"},{"issue":"6","key":"27720_CR70","doi-asserted-by":"publisher","first-page":"e1008607","DOI":"10.1371\/journal.ppat.1008607","volume":"16","author":"S Silva-Arrieta","year":"2020","unstructured":"Silva-Arrieta, S., Goulder, P. J. R. & Brander, C. Silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. PLoS Pathog. 16(6), e1008607 (2020).","journal-title":"PLoS Pathog"},{"issue":"10","key":"27720_CR71","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1517\/17460440903242283","volume":"4","author":"NC Toussaint","year":"2009","unstructured":"Toussaint, N. C. & Kohlbacher, O. Towards in silico design of epitope-based vaccines. Expert Opin. Drug Discov. 4(10), 1047\u20131060 (2009).","journal-title":"Expert Opin. Drug Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27720-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27720-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27720-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T11:03:12Z","timestamp":1765969392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27720-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27720"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27720-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43984"}}